A Clinical Study on the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of SHR-1819 Injection in Patients With Seasonal Allergic Rhinitis

• Status: RECRUITING
• Trial end date: 2025-12-01

Summary

This is a trial to evaluate the safety and efficacy of SHR-1819 injection in the treatment of patients with seasonal allergic rhinitis.

• Phase: PHASE2

Details

• Lead Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd